Cellular Immunology

• 

  Publication Venue For

  • The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma..  345:103964. 2019
  • Immunomodulatory, liver depot gene therapy for Pompe disease..  342:103737. 2019
  • Dendritic cell generated from CD34+ hematopoietic progenitors can be transfected with adenovirus containing gene of HBsAg and induce antigen-specific cytotoxic T cell responses.  240:14-21. 2006
  • Induction of α-fetoprotein-specific CD4- and CD8-mediated T-cell response using RNA-transfected dendritic cells.  239:144-150. 2006
  • Specific antihepatocellular carcinoma T cells generated by dendritic cells pulsed with hepatocellular carcinoma cell line HepG2 total RNA.  238:61-66. 2005
  • Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes..  237:17-27. 2005
  • Mechanisms of activation of the RAW264.7 macrophage cell line by transfected mammalian DNA..  229:31-40. 2004
  • The chemokine CX3CL1 regulates NK cell activity in vivo..  225:122-130. 2003
  • Expression profiling of a transformed thymocyte cell line undergoing maturation in vitro identifies multiple genes involved in positive selection..  221:64-79. 2003
  • Peripheral blood dendritic cells, but not monocyte-derived dendritic cells, can augment human NK cell function..  213:14-23. 2001
  • Generation of melanoma-specific, cytotoxic CD4(+) T helper 2 cells: requirement of both HLA-DR15 and Fas antigens on melanomas for their lysis by Th2 cells..  210:96-105. 2001
  • Stimulation of thymocyte proliferation by phosphorothioate DNA oligonucleotides..  201:14-21. 2000
  • TNFalpha and IL-4 regulation of hyaluronan binding to monocyte CD44 involves posttranslational modification of CD44..  193:209-218. 1999
  • Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes..  190:141-155. 1998
  • Endothelial antigen presentation: stimulation of previously activated but not naïve TCR-transgenic mouse T cells..  189:31-40. 1998
  • Human dendritic cells, pulsed with either melanoma tumor cell lysates or the gp100 peptide(280-288), induce pairs of T-cell cultures with similar phenotype and lytic activity..  186:63-74. 1998
  • Vaccination with dendritic cells inhibits the growth of hepatic metastases in B6 mice..  185:65-74. 1998
  • Immunotherapeutic potential of tumor antigen-pulsed and unpulsed dendritic cells generated from murine bone marrow..  179:84-95. 1997
  • An analysis of alternatively spliced CD45 mRNA transcripts during T cell maturation in humans..  177:109-118. 1997
  • Recognition and lysis of human melanoma by a CD3+, CD4+, CD8- T-cell clone restricted by HLA-A2..  172:52-59. 1996
  • Effect of irradiation on cytokine production, MHC antigen expression, and vaccine potential of interleukin-2 and interferon-gamma gene-modified melanoma cells..  171:246-254. 1996
  • Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha..  167:72-78. 1996
  • Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype..  166:141-153. 1995
  • Antigen-presenting cell lines internalize peptide antigens via fluid-phase endocytosis..  163:47-54. 1995
  • Identification of two subpopulations of rat monocytes expressing disparate molecular forms and quantities of CD43..  163:59-69. 1995
  • Disruption of intrathymic CD4-Ia interactions on immature CD4+CD8+ thymocytes results in diminished TCR expression on mature CD8+ T cell progeny..  161:22-27. 1995
  • Multiple CTL specificities against autologous HIV-1-infected BLCLs..  161:34-41. 1995
  • Transduction of human melanoma cells with interleukin-2 gene reduces tumorigenicity and enhances host antitumor immunity: a nude mouse model..  159:26-39. 1994
  • Characterization of a CD6 ligand(s) expressed on human- and murine-derived cell lines and murine lymphoid tissues..  158:353-364. 1994
  • ICAM-1 (CD54) expression on B lymphocytes is associated with their costimulatory function and can be increased by coactivation with IL-1 and IL-7..  156:414-423. 1994
  • Involvement of multiple factors in the clonal deletion of self-reactive T cells..  151:425-436. 1993
  • CD45 mAb induces cell adhesion in peripheral blood mononuclear cells via lymphocyte function-associated antigen-1 (LFA-1) and intercellular cell adhesion molecule 1 (ICAM-1)..  147:110-128. 1993
  • The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens..  147:148-157. 1993
  • Human anti-pneumococcal polysaccharide antibodies are secreted by the CD5- B cell lineage..  143:66-79. 1992
  • Mechanism of pokeweed mitogen inhibition of rhIL-4-induced human IgE synthesis..  140:357-369. 1992
  • Analysis of the expression of CD5 by human B cells and correlation with functional activity..  139:185-197. 1992
  • The effect of AZT on in vitro lymphokine-activated killer (LAK) activity in human immunodeficiency virus type-1 (HIV-1) infected individuals..  136:165-172. 1991
  • Pentoxifylline and other methyl xanthines inhibit interleukin-2 receptor expression in human lymphocytes..  135:314-325. 1991
  • Con A-induced suppressor cell function depends on the activation of the CD4+CD45RA inducer T cell subpopulation..  133:367-378. 1991
  • A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: characterization of a cellular protein and its relationship to p15E..  128:337-352. 1990
  • Molecular signals in B cell activation. I. Differential refractory effects of incomplete signaling by ionomycin or PMA relate to autocrine IL-2 production and IL-2R expression..  127:483-496. 1990
  • Molecular signals in B cell activation. II. IL-2-mediated signals are required in late G1 for transition to S phase after ionomycin and PMA treatment..  127:497-505. 1990
  • Modulation of in vitro autologous melanoma-specific cytotoxic T-cell responses by phorbol dibutyrate and ionomycin..  125:508-517. 1990
  • Monoclonal antibody OKT3-induced T cell proliferation: differential role of HLA class II determinants expressed by T cells and monocytes..  125:79-91. 1990
  • Purification, characterization, and structural elucidation of the active moiety of the previously called "suppressor activating factor (SAF)"..  125:92-106. 1990
  • Comparison of the effects of IL-1 alpha and TNF-alpha on phagocyte accumulation and murine antibacterial immunity..  123:9-22. 1989
  • Amplification of suppressor inducer pathway with monoclonal antibody, anti-2H4, identifying a novel epitope of the common leukocyte antigen/T200 antigen..  118:68-84. 1989
  • Early activation and cell cycle entry of resting B cells after Fab-anti-Ig treatment: role of receptor crosslinking..  118:53-67. 1989
  • Branhamella catarrhalis activates human B lymphocytes following interactions with surface IgD and class I major histocompatibility complex antigens..  112:78-88. 1988
  • DNA and immunoglobulin synthesis by rabbit peripheral blood lymphocytes in vitro: complete and incomplete stimulation..  107:455-464. 1987
  • Cyclosporine inhibition of CH series murine B-cell lymphomas..  107:219-226. 1987
  • Preexposure of resting B cells to interferon-gamma enhances their proliferative response to subsequent activation signals..  106:355-365. 1987
  • Altered cell-averaged microviscosity of murine peritoneal macrophages undergoing activation in vivo or in vitro..  104:232-244. 1987
  • Interferon-mediated protection of B16 melanoma cells from cytotoxicity by activated macrophages..  100:280-287. 1986
  • Cloning of mitogen- and antigen-reactive B lymphocytes on filter paper discs. II. Paratope frequencies within the mitogen-selected repertoire..  98:506-516. 1986
  • Regulation of the immune response. II. Concomitant idiotope-specific enhancement and suppression can result in a phenotypically normal response..  98:145-155. 1986
  • Anti-Sm autoantibodies in MRL mice: analysis of precursor frequency..  96:448-454. 1985
  • Inhibition of in vitro anti-DNA B-cell responses by cyclosporine..  94:195-204. 1985
  • Characterization of cytotoxic cells generated from in vitro cultures of murine bone marrow cells..  92:1-13. 1985
  • Selective inhibition of natural killer activity by the monoclonal antibodies OKT10 and VEP10 at the single cell level..  88:382-392. 1984
  • Cloning of B cells from autoimmune MRL-lpr/lpr and MRL.xid mice..  84:32-40. 1984
  • Mechanisms of polyclonal B-cell activation in autoimmune B6-lpr/lpr mice..  84:22-31. 1984
  • Age-dependent alterations of peritoneal exudate macrophages in autoimmune-prone and autoimmune-resistant mouse strains..  83:321-329. 1984
  • Antibody-dependent cytolysis (ADCC) of tumor cells by activated murine macrophages is a two-step process: quantification of target binding and subsequent target lysis..  83:170-180. 1984
  • Phorbol diester-induced H2O2 production by peritoneal macrophages. Different H2O2 production by macrophages from normal and BCG-infected mice despite comparable phorbol diester receptors..  80:405-415. 1983
  • Effect os xid on anti-DNA B-cell precursors..  78:326-332. 1983
  • Interferon action: effects of mouse alpha and beta interferons on rosette formation, phagocytosis, and surface-antigen expression of cells of the macrophage-type line RAW 309Cr.1..  73:128-140. 1982
  • The B-cell repertoire for autoantibodies: frequency of precursor cells for anti-DNA antibodies..  72:294-305. 1982
  • Changes in macrophages and their functions with aging in C57BL/6J, AKR/J, and SJL/J mice..  69:227-234. 1982
  • Interaction of macrophages and lymphocytes for lymphokine production and cellular proliferation..  56:487-501. 1980
  • Mechanism of Epstein-Barr virus-induced human B-lymphocyte activation..  56:518-525. 1980
  • Mechanisms of corticosteroid action on lymphocyte subpopulations. IV. Effects of in vitro hydrocortisone on naturally occuring and mitogen-induced suppressor cells in man..  44:157-168. 1979
  • Mechanisms of corticosteroid action on lymphocyte subpopulations. V. Effects of in vivo hydrocortisone on the circulatory kinetics and function of naturally occuring and mitogen-induced suppressor cells in man..  44:169-178. 1979
  • Modulation of lymphocyte functions by group A streptococcal membrane..  42:3-17. 1979
  • Preparation and characterization of lymphocyte-activating factor (LAF) from acute monocytic and myelomonocytic leukemia cells..  41:199-206. 1978
  • Activation of human B lymphocytes. VI. Immunoregulation of antibody production by mitogen-induced and naturally occurring cells in normal individuals..  36:294-302. 1978
  • Characterization of human chemotactic lymphokine production induced by mitogens and mixed leukocyte reactions using a new microassay..  30:225-235. 1977
  • Influenza-induced depression of monocyte chemotaxis: Reversal by levamisole.  32:234-238. 1977
  • An inhibitor of macrophage function produced by neoplasms.  27:358-358. 1976
  • Inability of gestational hormones to account for the inhibitory effects of pregnancy plasmas on lymphocyte responses in vitro..  20:69-80. 1975
  • Protease activity of normal and PHA stimulated human lymphocytes..  18:210-219. 1975
  • Depression of lymphocyte transformation and exacerbation of Behcet's syndrome by ingestion of english walnuts..  9:263-272. 1973